340B Payment Proposal Would Increase Payment to Most Hospitals

340B Payment Proposal Would Increase Payment to Most Hospitals

In the 2027 Outpatient Prospective Payment System (OPPS) proposed rule, the Centers for Medicare and Medicaid Services(CMS) is considering a change to reimbursement for 340B drugs in Medicare Part B, from average sales price (ASP)+6 % to ASP-33.4%. Avalere Health previously estimated the impact of a similar change to Medicare payments. Based on CMS’s survey findings on average hospital acquisition cost for 340B drugs, we refreshed the analysis t…

FastFinance: Capex trends; new 340B bill

HFMA’s FastFinance newsletter is now a podcast. Host Rich Daly discusses the most current and relevant healthcare news, delivered in an easily digestible format. Hospital and health system capital expenditures in fiscal 2025 reached their highest since the start of the financial crisis in 2008, according to Fitch Ratings Also, this week’s Weird Number: $137 billion. That’s the estimated annual spending on state-directed payments, of which 84% go…

Column: Remembering a 340B Legend Who Will Not Be Forgotten

Soon after President George H.W. Bush signed the 340B law in November 1992, 10 hospital pharmacy directors from across the [...] The post Column: Remembering a 340B Legend Who Will Not Be Forgotten appeared first on 340B Report.